Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026

{
  "signal_id": "9434ed34-6c00-3987-c8e0-e6786a8c7564",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-07-16T12:30:00+00:00",
  "company": {
    "name": "Caris Life Sciences",
    "domain": "carislifesciences.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/caris-life-sciences-to-report-second-quarter-2026-financial-results-on-august-5-2026-302827124.html",
    "title": "Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026",
    "excerpt": "IRVING, Texas , July 16, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI ), a leading TechBio company, today announced it will report second quarter 2026 financial results on Wednesday, August 5, 2026. Caris Life Sciences will host a live webcast at 3:30 p.m. CT (4:30 p.m. ET) to discuss the financial results. Webcast Details: Date: Wednesday, August 5, 2026 Time: 3:30 p.m. CT (4:30 p.m. ET) Live Webcast: https://edge.media-server.com/mmc/p/ff8xb4qs A replay of the webcast will be available shortly after the conclusion of the call on the Investor Relations section of the Caris Life Sciences website at CarisLifeSciences.com. About Caris Life Sciences Caris Life Sciences® (Caris) is a leading TechBio company actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Genome, Whole Exome and Whole Transcriptome Sequencing), advanced AI and machine learning, Caris has created the large-scale, multimodal clinico-genomic database and computing capability needed to analyze and further unravel the molecular complexity of disease. This convergence of next-generation sequencing, AI and machine learning technologies and high-performance computing provides a differentiated platform for developing the latest generation of advanced precision medicine diagnostic solutions for early detection, diagnosis...",
    "summary": "Caris Life Sciences will report its financial results for the second quarter of 2026 on August 5, 2026.",
    "location": "Irving, Texas, USA",
    "planning": true,
    "image_url": "https://mmx.prnewswire.com/media/MS863020/Caris-Life-Sciences-Logo.jpg?id=OA2765614&p=facebook",
    "confidence": 0.9,
    "published_at": "2026-07-16T12:30:00Z",
    "location_data": [
      {
        "city": "Irving",
        "state": "Texas",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-08-05",
    "article_sentence": "Caris Life Sciences ® (NASDAQ: CAI ), a leading TechBio company, today announced it will report second quarter 2026 financial results on Wednesday, August 5, 2026."
  }
}

curl https://signals.autobound.ai/v1/signals/9434ed34-6c00-3987-c8e0-e6786a8c7564 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"carislifesciences.com","limit":20}'